Cargando…

Sustained CD4(+) T cell-driven lymphopenia without a compensatory IL-7/IL-15 response among high-grade glioma patients treated with radiation and temozolomide

Prolonged lymphopenia correlating with decreased survival commonly occurs among glioma patients undergoing radiation therapy (RT) and temozolomide (TMZ) treatment. To better understand the pathophysiology of this phenomenon, we prospectively monitored serum cytokine levels and lymphocyte subsets in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ellsworth, Susannah, Balmanoukian, Ani, Kos, Ferdynand, Nirschl, Christopher J, Nirschl, Thomas R, Grossman, Stuart A, Luznik, Leo, Drake, Charles G
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Landes Bioscience 2014
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4004618/ https://www.ncbi.nlm.nih.gov/pubmed/24790790 http://dx.doi.org/10.4161/onci.27357

Ejemplares similares

Field size effects on the risk and severity of treatment-induced lymphopenia in patients undergoing radiation therapy for solid tumors
por: Ellsworth, Susannah G.
Publicado: (2018)

Lymphopenia in interleukin (IL)-7 gene-deleted mice identifies IL-7 as a nonredundant cytokine
Publicado: (1995)

IL-6 drives T cell death to participate in lymphopenia in COVID-19
por: Zhou, Xiaoqi, et al.
Publicado: (2022)

Temozolomide and Reirradiation in Recurrent Grade II Brain Glioma
por: Osman, Mohammed A
Publicado: (2014)

Depatux-M and temozolomide in advanced high-grade glioma
por: Hirsch, Sophie, et al.
Publicado: (2020)

Potential contribution of increased soluble IL-2R to lymphopenia in COVID-19 patients
por: Zhang, Yaguang, et al.
Publicado: (2020)

IL-24 intrinsically regulates Th17 cell pathogenicity in mice
por: Sie, Christopher, et al.
Publicado: (2022)

Radiation-Induced Lymphopenia Risks of Photon Versus Proton Therapy for Esophageal Cancer Patients
por: Ebrahimi, Saba, et al.
Publicado: (2021)

Temozolomide in paediatric high-grade glioma: a key for combination therapy?
por: Verschuur, A C, et al.
Publicado: (2004)

A Systematic Review and Meta-analysis of the Impact of Radiation-Related Lymphopenia on Outcomes in High-Grade Gliomas
por: Mallick, Supriya, et al.
Publicado: (2022)

Upscaling of bio-nano-processes: selective bioseparation by magnetic particles
por: Nirschl, Hermann, et al.
Publicado: (2014)

Temozolomide in malignant glioma
por: Dresemann, Gregor
Publicado: (2010)

Monitoring temozolomide treatment of low-grade glioma with proton magnetic resonance spectroscopy
por: Murphy, P S, et al.
Publicado: (2004)

Recurrence patterns in patients with high-grade glioma following temozolomide-based chemoradiotherapy
por: Zhou, Xiaofeng, et al.
Publicado: (2016)

Expression of neuropilin-1 on in vivo induced regulatory T cells
por: Nirschl, Christopher J, et al.
Publicado: (2013)

IL-24 Induces Apoptosis via Upregulation of RNA-Activated Protein Kinase and Enhances Temozolomide-Induced Apoptosis in Glioma Cells
por: Hu, Chang-Wei, et al.
Publicado: (2015)

IL-15 signaling promotes adoptive effector T-cell survival and memory formation in irradiation-induced lymphopenia
por: Xu, Aizhang, et al.
Publicado: (2016)

Discovery of a Conditionally Activated IL-2 that Promotes Antitumor Immunity and Induces Tumor Regression
por: Nirschl, Christopher J., et al.
Publicado: (2022)

Combination of temozolomide with immunocytokine F16–IL2 for the treatment of glioblastoma
por: Pedretti, M, et al.
Publicado: (2010)

Seizure reduction is a prognostic marker in low-grade glioma patients treated with temozolomide
por: Koekkoek, Johan A. F., et al.
Publicado: (2015)

Bevacizumab in temozolomide refractory high-grade gliomas: single-centre experience and review of the literature
por: Jeck, Jennifer, et al.
Publicado: (2018)

Radiation and chemotherapy for high‐risk lower grade gliomas: Choosing between temozolomide and PCV
por: McDuff, Susan G. R., et al.
Publicado: (2019)

Lymphopenia, Lymphopenia-Induced Proliferation, and Autoimmunity
por: Sheu, Ting-Ting, et al.
Publicado: (2021)

Current Concepts in Examination and Treatment of Elbow Tendon Injury
por: Ellenbecker, Todd S., et al.
Publicado: (2013)

Conformational Changes of Calmodulin on Calcium and Peptide Binding Monitored by Film Bulk Acoustic Resonators
por: Nirschl, Martin, et al.
Publicado: (2011)

Review of Transducer Principles for Label-Free Biomolecular Interaction Analysis
por: Nirschl, Martin, et al.
Publicado: (2011)

Characterization of Fractal Structures by Spray Flame Synthesis Using X-ray Scattering
por: Simmler, Mira, et al.
Publicado: (2022)

Soft Sensor Development for Real-Time Process Monitoring of Multidimensional Fractionation in Tubular Centrifuges
por: Winkler, Marvin, et al.
Publicado: (2021)

How to Achieve High Encapsulation Efficiencies for Macromolecular and Sensitive APIs in Liposomes
por: Ullmann, Kirsten, et al.
Publicado: (2021)

Separation of Microplastic Particles from Sewage Sludge Extracts Using Magnetic Seeded Filtration
por: Rhein, Frank, et al.
Publicado: (2022)

Common variable immunodeficiency and natural killer cell lymphopenia caused by Ets-binding site mutation in the IL-2 receptor γ (IL2RG) gene promoter
por: Chandra, Anita, et al.
Publicado: (2016)

Severe Radiation-Induced Lymphopenia Attenuates the Benefit of Durvalumab After Concurrent Chemoradiotherapy for NSCLC
por: Jing, Wang, et al.
Publicado: (2022)

Predicting the outcome of grade II glioma treated with temozolomide using proton magnetic resonance spectroscopy
por: Guillevin, R, et al.
Publicado: (2011)

Efficacy and safety of long-term therapy for high-grade glioma with temozolomide: A meta-analysis
por: Xu, Weilin, et al.
Publicado: (2017)

ACT-18 SHOULD THE DOSE OF TEMOZOLOMIDE BE DECREASED FOR PATIENTS WITH HIGH-GRADE GLIOMAS WHO ARE ON HEMODIALYSIS?
por: Muto, Jun, et al.
Publicado: (2019)

Nidogen-1 expression is associated with overall survival and temozolomide sensitivity in low-grade glioma patients
por: Zhang, Baiwei, et al.
Publicado: (2021)

Anlotinib Alone or in Combination With Temozolomide in the Treatment of Recurrent High-Grade Glioma: A Retrospective Analysis
por: Yang, Qunying, et al.
Publicado: (2021)

Long-term adjuvant administration of temozolomide impacts serum ions concentration in high-grade glioma
por: Zhong, Liyun, et al.
Publicado: (2022)

Intrinsic immune evasion patterns predict temozolomide sensitivity and immunotherapy response in lower-grade gliomas
por: Tu, Zewei, et al.
Publicado: (2022)

Efficacy of apatinib combined with temozolomide in the treatment of recurrent high‑grade glioma: A meta‑analysis
por: Li, Guanglie, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_oridlmsieet36i80pevuc67q05